DRUG DISCOVERY STRATEGIES USING DEEP LEARNING MODELS

The R&D Drug Discovery System using an Ensemble AI Framework demonstrates the potential of integrating multi-omics data with advanced deep learning and ensemble techniques to deliver a reliable and intelligent solution for predicting drug efficacy and toxicity. By combining multiomics integration with predictive modeling, the system improves the performance and precision of preclinical drug assessment compared to traditional experimental methods. laboratory testing, this framework provides faster and datadriven insights, reducing both research costs and time.. The platform’s modularity ensures a high degree of Domain Versatility, making it a viable asset for enterprise pharmaceutical R&D, academic bio-foundries, and precision clinical environments. It establishes a new benchmark for computational pharmacology where the acceleration of lead-compound prioritization directly correlates to reduced clinical attrition and optimized resource allocation. Finally, incorporating multimodal data combining omics with chemical, imaging, or clinical datasets could enhance predictive performance and reduce false. Accuracy in this system typically ranges between 85% to 95%, depending on the dataset quality and model used.

Ballard, J. L., Wang, Z., Li, W., Shen, L., & Long, Q. (2024). Deep learning-based approaches for multi-omics data integration and analysis. BioData Mining, 17(38). Cheng, Z., Yan, Q., Ding, D., & Ding, Y. (2025). A scalable and robust ensemble deep learning method applied for predicting drugtarget interactions. Interdisciplinary    Sciences: Computational Life Sciences. Wang, Y., Yang, Y., Chen, S., & Wang, J. (2021). DeepDRK: A deep learning kernel-based multi-omics integration framework for drug repurposing. Briefings in Bioinformatics, 22(5), bbab048. Zitnik, M., Agrawal, M., & Leskovec, J. (2018). A graph convolutional network approach to modelling polypharmacy side effects. Bioinformatics, 34(13), i457–i466. Chen,       H.,    Engkvist,        O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018). The growth of deep learning within drug discovery. Drug Discovery Today, 23(6), 1241–1250. Ching, T., Himmelstein, D. S., BeaulieuJones, B. K., et al. (2018). Opportunities and obstacles for deep learning in biology and medicine. Journal of The Royal Society Interface, 15(141), 20170387. Ghosh, S., Mollah, M. N. H., & Hasan, M. (2020). A review on deep learning in drug discovery. Computers in Biology and Medicine, 123, 103843.. Zhang, W., Chen, Y., Liu, F., et al. (2021). Predicting drug–disease associations by integrating multi-omics data with graph neural networks. Briefings in Bioinformatics, 22(5), bbab045.